For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

就在 11 月 17 日，这款风靡全球的「减肥神药」正式在中国上市，公立医院首张司美格鲁肽用于减重适应症的处方将于下周在上海开出。 需要注意的是， 司美格鲁肽 是处方药物，针对的是肥胖症患者，这和社交媒体上被大肆宣传的「减肥神药」适用范围或许有所不同 ...

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...

If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

11月18日，丹麦大型制药企业诺和诺德（NovoNordisk）发布消息称，已开始在中国销售减肥药物“Wegovy”。受肥胖困扰的人呈现增加趋势的中国一直被视为减肥药物的潜力市场。与减肥药率先普及的美国市场相比，诺和诺德预计将以较低的价格来开拓当地需 ...

More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

The guidelines are part of a national trend by municipal governments and private firms struggling to manage ballooning costs ...